Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$13.84 - $20.79 $64,964 - $97,588
-4,694 Reduced 23.84%
14,994 $219,000
Q2 2023

Aug 14, 2023

BUY
$10.7 - $17.48 $76,216 - $124,510
7,123 Added 56.69%
19,688 $334,000
Q1 2023

May 15, 2023

SELL
$6.45 - $14.48 $57,714 - $129,567
-8,948 Reduced 41.59%
12,565 $175,000
Q4 2022

Feb 14, 2023

BUY
$4.53 - $7.55 $97,453 - $162,423
21,513 New
21,513 $141,000

Others Institutions Holding RCEL

About AVITA Medical, Inc.


  • Ticker RCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 25,030,900
  • Market Cap $217M
  • Description
  • AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...
More about RCEL
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.